Feedback / Questions
alpibectir (BVL-GSK098) - BioVersys, GSK
https://www.manilatimes.net/2025/08/27/tmt-newswire/globenewswire/bioversys-receives-ema-orphan-designation-for-the-combination-of-alpibectir-and-ethionamide-for-the-treatment-of-tuberculosis/2174298
Aug 26, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next